Article
Brief Report: Human Acute Myeloid Leukemia Reprogramming to Pluripotency Is a Rare Event and Selects for Patient Hematopoietic Cells Devoid of Leukemic Mutations.
Stem cells (Dayton, Ohio) - 1 Sept 2017
Lee Jong-Hee, Salci Kyle R, Reid Jennifer C, Orlando Luca, Tanasijevic Borko, Shapovalova Zoya, Bhatia Mickie
Abstract excerpt
Induced pluripotent stem cell reprogramming has provided critical insights into disease processes by modeling the genetics and related clinical pathophysiology. Human cancer represents highly diverse genetics, as well as inter- and intra-patient heterogeneity, where cellular model systems capable of capturing this disease complexity would be invaluable. Acute myeloid leukemia (AML) represents one of most...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
